The Value of Neurospecific Protein S-100 and Lipoproteins in the Development of Multiple Sclerosis

Authors

  • Markhamat M. Yakubova1, Mukaddas A. Mukhiddinova2

DOI:

https://doi.org/10.37506/ijfmt.v14i4.12809

Keywords:

Multiple sclerosisneurospecific protein lipoproteins central nervous systemdemyelinating diseases.

Abstract

This article describes the clinical picture of multiple sclerosis (MS) depending on indices of the neurospecific
protein s-100? and low-density lipoproteins. In patients with MS in the phase of activity, high levels of
s-100? protein and LDL were found. It means that in patients with MS, demyelination and degeneration
process continues, and as a result, patients are more likely to develop new symptoms. Thus, the study results
of s-100? protein and LDL can be used to predict possible development of adverse symptoms in multiple
sclerosis.

Author Biography

  • Markhamat M. Yakubova1, Mukaddas A. Mukhiddinova2

    1MD, Professor, Department of Neurology, Tashkent Medical Academy, Farobiy 2, Tashkent, Uzbekistan, 100109,
    2MD, PhD, Clinical Neurologist in Clinic Medion, Tashkent, Uzbekistan

Downloads

Published

2020-10-29

Issue

Vol. 14 No. 4 (2020): Indian Journal of Forensic Medicine & Toxicology

Section

Articles

License

https://creativecommons.org/licenses/by-nc/2.0/deed.en

How to Cite

The Value of Neurospecific Protein S-100 and Lipoproteins in the Development of Multiple Sclerosis. (2020). Indian Journal of Forensic Medicine & Toxicology, 14(4), 7361-7363. https://doi.org/10.37506/ijfmt.v14i4.12809